6.11 -0.27 (-4.29%)
NKTR
Stock Details
Last Trade:6.11 Change:-0.27 (-4.29%) Prev Close:6.38 Open: 6.29 Days Range:6.00 – 6.42 52 Week Range: 2.45 - 7.13 Volume:1292079 P/E: N/AEPS:-0.27
View AllRecent Alerts 07/04/09
Recent Alert on 06/23/09 at 8:28am
Brean Murray Initiates Coverage on Nektar Therapeutics (NKTR) with a Buy; Expect Substantial Value Creation Through Partnerships
Brean Murray Initiates Coverage on Nektar Therapeutics (NKTR) with a Buy; Expect Substantial Value Creation Through Partnerships
Brean Murray initiates coverage on Nektar Therapeutics (Nasdaq: NKTR) with a Buy. Price target $10. Brean analyst says, "The biggest potential value driver at present is the NKTR-118/119 program in opioid induced constipation (OIC), and the primary... Read More
Recent Alert on 06/19/09 at 9:33am
Morning Movers 6/19: ZZ, OCLS, SWHC, GLUU, NKTR Higher; TSFG, ETFC, TNK, SSL Lower
Morning Movers 6/19: ZZ, OCLS, SWHC, GLUU, NKTR Higher; TSFG, ETFC, TNK, SSL Lower
Recent Alert on 06/19/09 at 8:57am
Morgan Joseph Reiterates a 'Buy' on Nektar Therapeutics (NKTR); Partner Momentum Building
Morgan Joseph Reiterates a 'Buy' on Nektar Therapeutics (NKTR); Partner Momentum Building
Recent Alert on 05/14/09 at 11:40am
Unusual 11 Mid-Day Movers 5/14: CAEI, GIL, NKTR, FBC Higher; GIL, BEXP, ACMR, GASS, ENS Lower
Unusual 11 Mid-Day Movers 5/14: CAEI, GIL, NKTR, FBC Higher; GIL, BEXP, ACMR, GASS, ENS Lower
Recent Alert on 05/14/09 at 9:49am
Nektar Therapeutics (NKTR) Announces UCB's Cimzia Approved by U.S. FDA for Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Nektar Therapeutics (NKTR) Announces UCB's Cimzia Approved by U.S. FDA for Patients Suffering From Moderate to Severe Rheumatoid Arthritis
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 05/14/09 at 4:15pm
Closing Bell: Bulls remind bears of their presence (WMT, CEG, BRK.A, MEDX, RMBS, NKTR, DGI)
Closing Bell: Bulls remind bears of their presence (WMT, CEG, BRK.A, MEDX, RMBS, NKTR, DGI)
Blog Posts on 04/07/09 at 11:00am
Analyst upgrades, downgrades and initiations: MSFT, AXP, RBS, FIATY, NFLX ...
Analyst upgrades, downgrades and initiations: MSFT, AXP, RBS, FIATY, NFLX ...
Blog Posts on 03/02/09 at 8:29pm
Nektar Therapeutics F4Q08 and Year End 2008 Earnings Call Transcript
Nektar Therapeutics F4Q08 and Year End 2008 Earnings Call Transcript